Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1980 Aug;39(4):377–380. doi: 10.1136/ard.39.4.377

Methylprednisolone pulse therapy for nonrenal lupus erythematosus.

S Eyanson, M H Passo, M A Aldo-Benson, M D Benson
PMCID: PMC1000560  PMID: 6776913

Abstract

High-dose intravenous methylprednisolone therapy has previously been shown to be efficacious in the treatment of renal lupus erythematosus. The present report presents 2 patients with life-threatening, nonrenal lupus erythematosus. One patient had coma and seizures, while the other had sever thrombocytopenia and anaemia. Both had failed to respond to oral corticosteroid therapy in high doses but had dramatic clinical responses with intravenous methylprednisolone given in 'pulses.' Possible mechanisms of clinical improvement are discussed.

Full text

PDF
377

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOGGS D. R., ATHENS J. W., CARTWRIGHT G. E., WINTROBE M. M. THE EFFECT OF ADRENAL GLUCOCORTICOSTEROIDS UPON THE CELLULAR COMPOSITION OF INFLAMMATORY EXUDATES. Am J Pathol. 1964 May;44:763–773. [PMC free article] [PubMed] [Google Scholar]
  2. Bell P. R., Briggs J. D., Calman K. C., Paton A. M., Wood R. F., Macpherson S. G., Kyle K. Reversal of acute clinical and experimental organ rejection using large doses of intravenous prednisolone. Lancet. 1971 May 1;1(7705):876–880. doi: 10.1016/s0140-6736(71)92441-x. [DOI] [PubMed] [Google Scholar]
  3. Butler W. T., Rossen R. D. Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone. J Clin Invest. 1973 Oct;52(10):2629–2640. doi: 10.1172/JCI107455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cathcart E. S., Idelson B. A., Scheinberg M. A., Couser W. G. Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis. Lancet. 1976 Jan 24;1(7952):163–166. doi: 10.1016/s0140-6736(76)91272-1. [DOI] [PubMed] [Google Scholar]
  5. Claman H. N. Corticosteroids and lymphoid cells. N Engl J Med. 1972 Aug 24;287(8):388–397. doi: 10.1056/NEJM197208242870806. [DOI] [PubMed] [Google Scholar]
  6. Cole B. R., Brocklebank J. T., Kienstra R. A., Kissane J. M., Robson A. M. "Pulse" methylprednisolone therapy in the treatment of severe glomerulonephritis. J Pediatr. 1976 Feb;88(2):307–314. doi: 10.1016/s0022-3476(76)81009-8. [DOI] [PubMed] [Google Scholar]
  7. David D. S., Grieco M. H., Cushman P., Jr Adrenal glucocorticoids after twenty years. A review of their clinically relevant consequences. J Chronic Dis. 1970 Mar;22(10):637–711. doi: 10.1016/0021-9681(70)90078-0. [DOI] [PubMed] [Google Scholar]
  8. Fan P. T., Yu D. T., Clements P. J., Fowlston S., Eisman J., Bluestone R. Effect of corticosteroids on the human immune response: comparison of one and three daily 1 gm intravenous pulses of methylprednisolone. J Lab Clin Med. 1978 Apr;91(4):625–634. [PubMed] [Google Scholar]
  9. Fauci A. S., Dale D. C., Balow J. E. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med. 1976 Mar;84(3):304–315. doi: 10.7326/0003-4819-84-3-304. [DOI] [PubMed] [Google Scholar]
  10. Feduska N. J., Turcotte J. G., Gikas P. W., Bacon G. E., Penner J. A. Reversal of renal allograft rejection with intravenous methylprednisolone "pulse" therapy. J Surg Res. 1972 Mar;12(3):208–215. doi: 10.1016/0022-4804(72)90110-2. [DOI] [PubMed] [Google Scholar]
  11. Levinsky R. J., Cameron J. S., Soothill J. F. Serum immune complexes and disease activity in lupus nephritis. Lancet. 1977 Mar 12;1(8011):564–567. doi: 10.1016/s0140-6736(77)91998-5. [DOI] [PubMed] [Google Scholar]
  12. Nebout T., Sobel A., Lagrue G. Intravenous methylprednisolone pulses in diffuse proliferative lupus nephritis. Lancet. 1977 Apr 23;1(8017):909–909. doi: 10.1016/s0140-6736(77)91239-9. [DOI] [PubMed] [Google Scholar]
  13. Ponticelli C., Tarantino A., Pioltelli P., Invernizzi F. High-dose methylprednisolone pulses in active lupus nephritis. Lancet. 1977 May 14;1(8020):1063–1063. doi: 10.1016/s0140-6736(77)91307-1. [DOI] [PubMed] [Google Scholar]
  14. WEISSMANN G., THOMAS L. Studies on lysosomes. I. The effects of endotoxin, endotoxin tolerance, and cortisone on the release of acid hydrolases from a granular fraction of rabbit liver. J Exp Med. 1962 Oct 1;116:433–450. doi: 10.1084/jem.116.4.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Yu D. T., Clements P. J., Paulus H. E., Peter J. B., Levy J., Barnett E. V. Human lymphocyte subpopulations. Effect of corticosteroids. J Clin Invest. 1974 Feb;53(2):565–571. doi: 10.1172/JCI107591. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES